Latest press releases

Winding down to the EU IVD and Medical Devices Regulations Deadlines: The Finish Lines in Sight?

Posted on 26.11.2019

26 November 2019 – Today marks the half-way point of the EU IVD Regulation’s (IVDR) five-year transition period and the start of the final six months to the EU Medical Devices Regulation’s (MDR) date of application.

Joint Statement for an Ambitious Horizon Europe Programme

Posted on 16.09.2019

We, the undersigned 93 European associations representing key European research & innovation stakeholders, hereby urge the EU Institutions to make research, development and innovation (RD&I) a priority within the next Multiannual Financial Framework 2021-2027. We call on the Council of the EU to raise the budget allocated to the Horizon Europe programme to at least €120 billion (in 2018 prices), of which at least 60% should be dedicated to the “Global Challenges and European Industrial Competitiveness” pillar.

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

Posted on 12.09.2019

Brussels, 12 September 2019 - MedTech Europe has joined 16 organisations active in human and animal health in sending an open letter to Members of the European Parliament urging them to bring antimicrobial resistance (AMR) to the forefront of EU interinstitutional discussions and to support the establishment of a dedicated AMR parliamentary group.

Medtech industry calls on all stakeholders to support digital health interoperability standards specified by the European Commission

Posted on 10.07.2019

MedTech Europe statement on EPSCO Meeting – June 2019

Posted on 20.06.2019

MedTech Europe recognizes the outcome of the Member States’ debate on the preparedness status of MDR/IVDR implementation held during the EPSCO Council meeting on 14 June. MedTech Europe welcomes the attention given by Member States to the serious consequences these challenges can cause to the quality of care for European patients.

Council Conclusions on combatting Antimicrobial Resistance (AMR) highlight the continued need to keep the topic high on the political agenda

Posted on 14.06.2019

Brussels, 14 June 2019 – Today, the Employment, Social Policy, Health and Consumer Affairs Council adopted its Council Conclusions on combatting Antimicrobial Resistance. MedTech Europe welcomes the leadership that the Council has taken on this global health challenge and in particular the attention directed to the importance of infection prevention and control as well as to antimicrobial stewardship programmes.

MedTech Europe compares Funding Mechanisms for Innovation across Europe

Posted on 16.05.2019

Paris, 16 May 2019 – MedTech Europe completed a commissioned project classifying existing mechanisms in Europe that fund medical technology innovation. The project ‘Taxonomy of Value-Based Access Programmes (VBAPs) / Funding for Innovation’ looks at 23 European countries and explores the benefits of such programmes in facilitating the uptake of innovation into the healthcare systems.

Exchange of views on ‘Implant Files’ in the European Parliament: MedTech Europe reaffirms its commitment to patient safety

Posted on 28.02.2019

On 27 February, MedTech Europe participated in an exchange of views before the Committee for Environment Public Health and Food Safety (ENVI) at the European Parliament (EP). Other participants included the International Consortium of Investigative Journalists (ICIJ) and the European Commission.

MedTech Europe response to ICIJ investigation

Posted on 27.11.2018

As the medical device industry, we have a genuine responsibility to the patients we serve. Providing products that work and are safe is at the core of what we do. We continue to uphold our commitment in providing safe medical devices that help save and improve people’s lives.

European Parliament further clarifies Commission proposal on HTA for medical technologies, paving the way for negotiations with the Council

Posted on 04.10.2018

European health community issues key questions Article 50 negotiations must answer for patients and public health

Posted on 08.03.2018

The European Health Community has warned that time is running out to secure patients’ interests in Brexit negotiations.  With Phase 2 of the negotiations looming, health groups across Europe have drawn up a list of crucial unanswered questions that must be answered by the EU and UK negotiators to ‘put patients first’ in the negotiations.

Joint Statement on Phase-Out of Direct Sponsorships

Posted on 03.01.2018